Dr. Brian S. Henick, a medical oncologist at Columbia University Irving Medical Center and director of the phase 1 program ...
Candel Therapeutics Inc (NASDAQ:CADL) has reported updated clinical data showing extended survival outcomes from its ongoing ...
Cemiplimab monotherapy offers quality-of-life benefits over chemotherapy in patients with advanced NSCLC and PD-L1 expression ...
Extended long-term survival observed after an additional year of follow-up in ongoing phase 2a clinical trial, with 50% of 46 patients with ...
Background Pulmonary fibrosis (PF) caused by interstitial lung diseases (ILDs) affects up to 0.1% of the global population.
The new €3.2M (US$3.7M) research lab will investigate immunogenic cell death mechanisms in lung cancer to improve how ...
Oncology leaders appearing in Atlanta, Georgia, including several from Winship Cancer Institute from Emory University School of Medicine, show how NGS biomarkers and MRD reshape NSCLC and hematology ...
Synthekine Inc., an engineered cytokine therapeutics company, today announced that updated clinical and translational data from a Phase 1a/1b clinical trial of its α/β biased IL-2 partial agonist, STK ...
Discover the Human Organ Atlas, a new open data repository that allows access to multiscale three-dimensional imaging of ...
Microscopic images of human tissue are a cornerstone of biomedical research and clinical diagnostics. Yet despite their ...
Google Earth’ for human organs made available online An international team of scientists and clinicians has announced, in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results